BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 27, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

RVX-208: Phase II amended

Resverlogix said it plans to expand and amend the suspended Phase II ASSURE (formerly ASSURE 1) trial of RVX-208. As a result, the company no longer plans to conduct the proposed Phase II ASSURE 2 trial. Resverlogix said ASSURE...

Read the full 181 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >